论文部分内容阅读
目的:研究并分析卡维地洛与胺碘酮合用治疗心律失常疾病的临床效果。方法:选取我院在2015年3月到2017年3月期间收治的60例心律失常疾病患者作为研究对象,按照用药方式的不同随机分为参照组和实验组,每组患者各30例。其中,实验组患者给予卡维地洛与胺碘酮联合治疗,参照组患者给予单纯胺碘酮治疗,对比两组患者药物治疗后的临床效果。结果:对比两组患者的治疗有效率,组间差异显著,且p<0.05;对比治疗后两组患者的平均心率、左心室射血分数、收缩压以及超敏C反应蛋白水平,组间数据差异显著,且p<0.05。结论:对心律失常疾病患者予以卡维地洛与胺碘酮联合治疗,提高了治疗效果,明显改善了患者的病情和心功能症状,值得临床上借鉴以及进一步普及。
Objective: To study and analyze the clinical effect of combining carvedilol with amiodarone in the treatment of cardiac arrhythmia. Methods: Sixty patients with arrhythmia who were treated in our hospital from March 2015 to March 2017 were selected as study subjects and randomly divided into reference group and experimental group according to the way of treatment. Each group included 30 patients. Among them, the experimental group was treated with carvedilol and amiodarone, and the reference group was treated with amiodarone alone. The clinical effects of two groups of patients after drug treatment were compared. Results: Comparing the treatment efficiency of two groups, there was significant difference between the two groups (p <0.05). After comparing the average heart rate, left ventricular ejection fraction, systolic blood pressure and high-sensitivity C-reactive protein in two groups, The difference was significant, and p <0.05. Conclusion: The combined treatment of carvedilol and amiodarone in patients with arrhythmia can improve the curative effect, obviously improve the patient’s condition and the symptoms of cardiac function, which deserves clinical reference and further popularization.